New York, USA, Nov. 20, 2024 (GLOBE NEWSWIRE) — Market Overview:
The size of the in vitro diagnostics quality control market was evaluated to be USD 1.20 billion in 2023. The market is expected to flourish and grow from USD 1.26 billion in 2024 to USD 1.87 billion by 2032, showcasing a CAGR of 5.1% between 2024–2032.
Market Introduction:
Introduction to In Vitro Diagnostics Quality Control Market
The need for diagnostic laboratories has grown as a result of the high prevalence of conditions like diabetes, heart disease, and infectious diseases. To meet industry standards, boost procedure volume, and draw in more patients, many public and private laboratories go through laboratory accreditation processes. The demand for In Vitro Diagnostics Quality Control (QC) products is expected to rise globally as more laboratories are established.
The rising number of patient confidence is a result of the growing number of accredited clinical laboratories providing trustworthy IVD-based diagnostic services, which fuels the In vitro diagnostics quality control market’s demand. Growth in the number of accredited clinical laboratories providing reliable IVD-based diagnostic services boosts patient confidence, which fuels market demand.
Download Free Sample PDF Copy of the Report:
Market Report Scope and Attributes:
| Report Attribute | Details |
| Market Value in 2024 | USD 1.26 Billion |
| Market value by 2032 | USD 1.87 Billion |
| CAGR | 5.1% |
| Base Year | 2023 |
| Historical Data | 2019–2022 |
| Forecast Period | 2024–2032 |
Top Players in In Vitro Diagnostics Quality Control Market:
The In vitro diagnostics quality control market is characterized by a wide range of regional and international competitors competing for market share through geographic expansion, strategic alliances, and innovation. To meet the changing demands of healthcare providers, these businesses concentrate on developing innovative products that enhance safety, functionality, and cost-effectiveness.
- Abbott Laboratories
- Alpha-Tec Systems
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- CleanNA
- Danaher Corporation
- Fortress Diagnostics
- Grifols, S.A.
- Newland EMEA
- Helena Laboratories Corporation
- Maine Molecular Quality Controls, Inc.
- Microbiologics
- Microbix Biosystems
- Ortho-Clinical Diagnostics
- Qnostics
Request for a Discount on this Report Before Purchase:
Growth Driver for In Vitro Diagnostics Quality Control Market:
- Increased Infectious Disease and Chronic Illness Prevalence
The need for diagnostic testing and monitoring is greatly increased by the rising incidence of infectious diseases and chronic conditions. Rising geriatric populations, changing lifestyles, and urbanization are some of the factors contributing to the prevalence of chronic conditions like diabetes, cardiovascular diseases, and cancer. Because IVDs are used to identify patients who need therapies or particular treatments, they are useful in precision medicine.
- Increasing Technological Advancements in Diagnostic
In vitro diagnostics (IVD), next-generation sequencing (NGS), and point-of-care testing are examples of technological innovations that are speeding up turnaround times, improving test specificity, and expanding the range of conditions that can be detected. These developments will ultimately make more efficient and timely treatments simpler.
Regional Overview:
The research report provides market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the largest share of the in vitro diagnostics quality control market in 2023 due to the presence of highly developed healthcare infrastructure comprising numerous hospitals, clinical laboratories, and research institutions that drive substantial demand for quality control products.
Frequent and accurate diagnostic testing is more important because chronic diseases like diabetes, heart disease, and cancer are so common in North America. New quality control techniques are also being developed and adopted thanks to the region’s academic and research institutions’ active research and development. These combined factors cement North America’s leading position in the In Vitro Diagnostic Quality Control Market.
Recent Market Developments:
- In September 2023, NeoDx Biotech Labs, a startup based in Bengaluru, launched a real-time PCR-based diagnostic kit for Ankylosing Spondylitis, improving healthcare testing capabilities. The kit detects Human Leukocyte Antigen B27 in whole blood, aiding in early identification and treatment of related inflammatory disorders.
- In May 2024, Waters introduced a new software system, “Waters Connect,” for in-vitro diagnostics to fuel data integrity, accessibility, security, and compliance, which enables researchers to innovate effective medical tools in the market. It has the potential to reduce review time by around 50%, in line with its Waters TargetLynx software.
Inquire more about this report before purchase:
In Vitro Diagnostics Quality Control Market Segmentation:
By Product & Service:
- Quality Control Products
- Serum/Plasma Based Control
- Whole Blood-Based Control
- Urine Based Control
- Other Control
- Data Management Solutions
- Quality Assurance Services
By Technology:
- Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Hematology
- Coagulation/Hemostasis
- Other Technologies
By Manufacturer Type:
- Third-Party Controls
- Independent Controls
- Instrument Specific Controls
- Original Equipment Manufacturer Controls
By End User:
- Hospitals
- Clinical Laboratories
- Academic and Research Institutes
- Other End users
By Region:
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Report Coverage
More Trending Latest Reports by Polaris Market Research:
Ear Infection Treatment Market
Liver Metastases Treatment Market
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
